Status:

UNKNOWN

ICG for Visualization of the Ureters in DIE

Lead Sponsor:

Insel Gruppe AG, University Hospital Bern

Conditions:

Visualization of Ureters in Gynecological Surgery

Deep Infiltrative Endometriosis

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Endometriosis is a common condition with an incidence of approximately 10% of all women in the fertile phase. Deep infiltrating endometriosis (DIE) has been shown to be associated with high morbidity....

Detailed Description

Endometriosis is a common illness with an incidence of about 10% of all premenopausal women. Deep infiltrative endometriosis is associated with high morbidity. The resection of deep infiltrative endom...

Eligibility Criteria

Inclusion

  • Informed Consent as documented by signature
  • Age 18 or older
  • Premenopausal status (menopause is defined as amenorrhea lasting one year or longer)
  • Proven (by laparoscopy or MRI) or highly suspected (ultrasound or clinically) deep infiltrating endometriosis

Exclusion

  • No DIE detectable intraoperatively
  • Known or suspected allergy to iodine, shellfish, or ICG dye
  • Hyperthyroid metabolic state (excluding treated hyperthyroidism with euthyroid metabolic state)
  • Severe renal insufficiency (GFR \< 30ml/min)
  • Simultaneous therapy with beta-blockers
  • Pregnant (positive human chorionic gonadotropin in the blood) or breastfeeding women
  • Intention to become pregnant during the course of the study
  • Inability to follow the procedures of the study (due to language problems, psychological disorders, dementia)
  • Previous history of radiation therapy of the pelvis
  • Presence of medical conditions contraindicating general anesthesia or standard laparoscopic surgery
  • Active, non treated urinary tract infection
  • Active pyelonephritis
  • Women having undergone surgery for reimplantation of the ureters (UCNS) or nephrostomy

Key Trial Info

Start Date :

June 26 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT05206279

Start Date

June 26 2023

End Date

December 1 2025

Last Update

December 7 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Inselspital

Bern, Switzerland